Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D J LAURENCE

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
British Journal of Cancer|September 1, 1975
First British standard for carcinoembryonic antigen (CEA)D J Laurence, C Turberville, S G Anderson, et al.
Journal of Clinical Pathology. Supplement (Association of Clinical Pathologists)|January 1, 1975
Human tumour-associated and tumour-specific antigens: some concepts in relation to clinical oncologyA M Neville, A M Mackay, J Westwood, et al.
British Medical Journal|September 9, 1972
Carcinoembryonic antigen in the urine of patients with urothelial carcinomaR R Hall, D J Laurence, D Darcy, et al.
British Medical Journal|November 16, 1974
Role of serial plasma C.E.A. assays in detection of recurrent and metastatic colorectal carcinomasA M Mackay, S Patel, S Carter, et al.
Cancer|September 1, 1978
The monitoring role of plasma CEA alone and in association with other tumor markers in colorectal and mammary carcinomaA M Neville, S Patel, M Capp, et al.
Journal of Clinical Immunology|December 22, 2023
The Human GP130 Cytokine Receptor and Its Expression-an Atlas and Functional Taxonomy of Genetic VariantsYin-Huai Chen, Sarah van Zon, Alex Adams, et al.
British Medical Journal|September 9, 1972
Role of plasma carcinoembryonic antigen in diagnosis of gastrointestinal, mammary, and bronchial carcinomaD J Laurence, U Stevens, R Bettelheim, et al.
Lancet (London, England)|January 15, 1977
Biochemical markers in human breast cancerR C Coombes, T J Powles, J C Gazet, et al.
Drug Design, Development and Therapy|September 7, 2022
Characterization of Selective and Potent JAK1 Inhibitors Intended for the Inhaled Treatment of AsthmaMagnus Nilsson, Magdalena Rhedin, Ramon Hendrickx, et al.
Nature Immunology|May 23, 2017
BACH2 immunodeficiency illustrates an association between super-enhancers and haploinsufficiencyBehdad Afzali, Juha Grönholm, Jana Vandrovcova, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
British Journal of Cancer|September 1, 1975
First British standard for carcinoembryonic antigen (CEA)D J Laurence, C Turberville, S G Anderson, et al.
Journal of Clinical Pathology. Supplement (Association of Clinical Pathologists)|January 1, 1975
Human tumour-associated and tumour-specific antigens: some concepts in relation to clinical oncologyA M Neville, A M Mackay, J Westwood, et al.
British Medical Journal|September 9, 1972
Carcinoembryonic antigen in the urine of patients with urothelial carcinomaR R Hall, D J Laurence, D Darcy, et al.
British Medical Journal|November 16, 1974
Role of serial plasma C.E.A. assays in detection of recurrent and metastatic colorectal carcinomasA M Mackay, S Patel, S Carter, et al.
Cancer|September 1, 1978
The monitoring role of plasma CEA alone and in association with other tumor markers in colorectal and mammary carcinomaA M Neville, S Patel, M Capp, et al.
Journal of Clinical Immunology|December 22, 2023
The Human GP130 Cytokine Receptor and Its Expression-an Atlas and Functional Taxonomy of Genetic VariantsYin-Huai Chen, Sarah van Zon, Alex Adams, et al.
British Medical Journal|September 9, 1972
Role of plasma carcinoembryonic antigen in diagnosis of gastrointestinal, mammary, and bronchial carcinomaD J Laurence, U Stevens, R Bettelheim, et al.
Lancet (London, England)|January 15, 1977
Biochemical markers in human breast cancerR C Coombes, T J Powles, J C Gazet, et al.
Drug Design, Development and Therapy|September 7, 2022
Characterization of Selective and Potent JAK1 Inhibitors Intended for the Inhaled Treatment of AsthmaMagnus Nilsson, Magdalena Rhedin, Ramon Hendrickx, et al.
Nature Immunology|May 23, 2017
BACH2 immunodeficiency illustrates an association between super-enhancers and haploinsufficiencyBehdad Afzali, Juha Grönholm, Jana Vandrovcova, et al.
Pageof 2